London, UK --News Direct-- Creo Medical Group PLC

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive about the latest developments at the medical device company, following a successful appearance at Digestive Disease Week. Gulliford says that Creo Medical is "gaining a level of acceptance" both within its home market the UK and beyond, highlighting increasing interest from the burgeoning Asian market.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

[email protected]

View original content to download multimedia: https://newsdirect.com/news/creo-medical-group-gaining-a-level-of-acceptance-in-endoscopy-782131056

This news release was distributed by News Direct Corp. (“News Direct”). News Direct is an industry-leading content and news distribution platform. This news release and all materials included within this news release, including, without limitation, all images, trademarks and logos, are protected by copyrights, trademarks, service marks, patents or other proprietary rights and laws. If you copy, broadcast, download, store (in any medium), transmit, show or play any multimedia content from this release in public, you must properly attribute said content to the company or organization from which the news release originated unless otherwise sourced. News Direct makes no warranties with respect to the accuracy or completeness of the information contained in this news release. News Direct hereby disclaims all warranties, whether express, implied, statutory or otherwise, in connection with this news release and the content within this news release.